VELCADE TM (bortezomib) for Injection, or PS-341

TERMINATED · PHASE1 · Advanced Non-Small Cell Lung Cancer, Other Solid Tumors

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.